Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Research aims to transform haemophilia treatment

Research aims to transform haemophilia treatment

Date time 18 December, 2023
News Type News type Media release
Professor Philip Hogg, researcher in the Centenary Institute's Centre for Cancer Innovations, has received a National Health and Medical Research Council (NHMRC) Investigator Grant to undertake research aimed at revolutionising the treatment of haemophilia A.

A rare genetic disorder, haemophilia A is characterised by a deficiency of an essential blood-clotting protein called Factor VIII (FVIII), which leads to bleeding episodes, most commonly into the joints. This can lead to chronic pain, joint deformity, reduced mobility and increased mortality.

The grant, worth $2,953,040 over five years, will enable Professor Hogg and his team to investigate a recently discovered aspect of FVIII – differing structural forms of this blood protein, influenced by the presence or absence of essential chemical bonds called disulphide bonds.

Professor Hogg says that his research could make a big difference for people with haemophilia A with the research leading to the development of cheaper, safer and longer-lasting treatments. 

“Current treatment options for haemophilia A involve replacing the missing FVIII through infusions or by using gene therapy. However, these treatment approaches are limited in their effectiveness because the FVIII protein is inherently toxic,” said Professor Hogg.

“Commercial production of recombinant FVIII for replacement therapy is very expensive because the protein kills the cells it is produced in. Gene therapy to produce FVIII is promising but not durable as the liver cells that make the protein die over time and damage the liver.”

Professor Hogg believes that he may be able to identify a form of FVIII – based on its particular disulphide bond makeup – that overcomes these limitations. He will test more than 100 forms of the blood protein to identify a variant that is effective but less harmful to cells and patients.

“By identifying those forms of FVIII that are less toxic, we hope to improve the management of haemophilia A, reduce bleeding episodes and enhance the overall quality of life for those affected by this condition,” said Professor Hogg.

Professor Marc Pellegrini, Centenary Institute Executive Director, said the successful grant was an excellent outcome for an important project.

“Haemophilia A requires ongoing medical attention to help prevent or control bleeding and treatment regimes can be demanding and severely impact the daily lives of those affected by this disorder,” said Professor Pellegrini.

“I congratulate Professor Hogg on his successful grant. This exciting and potentially life-changing research could lead to improvements in treatments for haemophilia A that affects about 1 in every 5,000 males.”

NHMRC Investigator Grants support research across the four pillars of health and medical research – biomedical, clinical, public health and health services. The scheme allows the highest-performing researchers to pursue important new research directions, to form collaborations, and foster innovative and creative research.

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Research aims to transform haemophilia treatment

Download

Recent Stories

  • Prestigious editorial award for Professor Gorrell

    Professor Mark Gorrell from the Centenary Institute’s Centre for Cancer Innovations has been awarded a Springer Nature Editorial Contribution Award celebrating his outstanding editorial work for the highly respected journal Scientific Reports. The award recognises editorial board members who have made a notable contribution to the journal’s peer-review and publishing processes. Professor Gorrell has served ...
    News Type: Research News
    Date 16 Jun 2025
  • Serena Li, inaugural Chair of Centenary’s ReST Association

    Serena Li, a research assistant at the Centenary Institute, has recently been appointed as the Chair of the newly established ReST (Research Assistants, Support and Technicians) Association.
    News Type: Profiles
    Date 10 Jun 2025
  • Centenary Institute hosts TB research symposium

    The Centenary Institute has hosted the 2025 Annual Research Symposium of the ‘Centre of Research Excellence in Tuberculosis Elimination (TB-CRE)’.
    News Type: Events
    Date 02 Jun 2025
  • New discovery could improve treatment for people with haemophilia A

    Researchers from the Centenary Institute have uncovered a reason why some people with haemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies.
    News Type: Media release
    Date 28 May 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram